An approach to the hospitalized patient with urticaria and fever.
Dermatol Ther. 2011 Mar;24(2):187-95
Authors: Micheletti R, Rosenbach M
Urticaria is a common skin disorder with a long differential diagnosis. Most cas…

[Read more →]

Approach to the hospitalized patient with targetoid lesions.
Dermatol Ther. 2011 Mar;24(2):196-206
Authors: Hughey LC
Approaching the hospitalized patient with skin disease can be daunting. This article focuses on a pr…

[Read more →]

Cellulitis: diagnosis and management.
Dermatol Ther. 2011 Mar;24(2):229-39
Authors: Bailey E, Kroshinsky D
Cellulitis is an acute infection of the dermal and subcutaneous layers of the skin, often occurring after a loc…

[Read more →]

Related Articles

Therapy of environmental mycobacterial infections.

Dermatol Ther. 2008 May-Jun;21(3):162-6

Authors: Fabroni C, Buggiani G, Lotti T

Environmental mycobacteria are the causative factors of an increasing number of infections worldwide. Cutaneous infections as a result of environmental mycobacteria are often misdiagnosed, and their treatment is difficult because these agents can show in vivo and in vitro multidrug resistance. The most common environmental mycobacteria that can cause cutaneous infections are Mycobacterium fortuitum and Mycobacterium marinum. All mycobacteria are characterized by low pathogenicity and they can contaminate affected or traumatized skin only in immunocompetent subjects (mainly in fishermen, swimming-pool attendants, and aquarium owners) whereas medical and esthetic procedures are at risk for the infections because of the quick-growing mycobacteria. Immunocompromised subjects can instead easily develop environmental mycobacterial infections of differing degrees of severity.

PMID: 18564246 [PubMed - indexed for MEDLINE]

[Read more →]

Related Articles

Treatment and prevention of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.

Dermatol Ther. 2008 May-Jun;21(3):167-79

Authors: Popovich KJ, Hota B

Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) has emerged as a pathogen in the community with a range of clinical manifestations. Although skin and soft tissue infections (SSTIs) are the most common presentation, invasive and more virulent disease has been observed. Colonization and infection with CA-MRSA can occur in individuals with no prior healthcare exposures but also in distinct groups whose common characteristic appears to be close person-to-person contact. Outbreaks with CA-MRSA have occurred in day care centers, athletic teams, and prisons, and transmission has been documented among family members and within the hospital. Treatment of SSTIs involves incision and drainage, oral or parenteral antibiotic therapy, or topical therapy. Healthcare practitioners in outpatient and inpatient settings need to be familiar with prevention and treatment strategies for CA-MRSA.

PMID: 18564247 [PubMed - indexed for MEDLINE]

[Read more →]